X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (519) 519
Publication (33) 33
Book Chapter (13) 13
Dissertation (6) 6
Book Review (3) 3
Patent (2) 2
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (281) 281
female (190) 190
index medicus (190) 190
male (188) 188
gastroenterology & hepatology (182) 182
middle aged (154) 154
adult (148) 148
hepatitis b (106) 106
aged (101) 101
hepatitis b virus - genetics (92) 92
hepatitis b, chronic - drug therapy (86) 86
antiviral agents - therapeutic use (79) 79
hepatitis (74) 74
hepatitis b virus (71) 71
hepatocellular-carcinoma (63) 63
adolescent (60) 60
dna, viral - blood (58) 58
liver (57) 57
hepatitis b, chronic - virology (56) 56
infection (54) 54
treatment outcome (53) 53
hepatocellular carcinoma (52) 52
cirrhosis (48) 48
risk factors (48) 48
liver cancer (47) 47
dna (46) 46
risk (46) 46
health aspects (45) 45
therapy (44) 44
young adult (44) 44
interferon (43) 43
lamivudine (43) 43
genotype (41) 41
hepatitis b e antigens - blood (41) 41
research (41) 41
hepatitis b, chronic - complications (40) 40
hepatology (40) 40
infections (40) 40
virology (39) 39
care and treatment (37) 37
hepatitis b surface antigens - blood (37) 37
lamivudine - therapeutic use (36) 36
aged, 80 and over (35) 35
mutation (35) 35
infectious diseases (34) 34
liver diseases (34) 34
pharmacology & pharmacy (34) 34
deoxyribonucleic acid--dna (33) 33
hepatitis b virus - drug effects (33) 33
viral load (33) 33
analysis (32) 32
microbiology (32) 32
natural-history (32) 32
antigens (31) 31
gastroenterology and hepatology (31) 31
genetic aspects (31) 31
prevalence (31) 31
digestive system diseases (29) 29
disease (29) 29
time factors (29) 29
adefovir dipivoxil (28) 28
entecavir (28) 28
hepatitis b, chronic - blood (28) 28
antiviral agents (27) 27
follow-up studies (27) 27
medicine & public health (27) 27
mortality (27) 27
alanine transaminase - blood (26) 26
surface-antigen (26) 26
surgery (26) 26
development and progression (25) 25
hepatitis b virus - isolation & purification (25) 25
hepatitis b, chronic - immunology (25) 25
lamivudine therapy (25) 25
oncology (25) 25
chronic hepatitis b (24) 24
fibrosis (24) 24
liver cirrhosis (24) 24
patients (24) 24
cancer (23) 23
carcinoma, hepatocellular - virology (23) 23
guanine - analogs & derivatives (23) 23
immunology (23) 23
viruses (23) 23
drug therapy (22) 22
guanine - therapeutic use (22) 22
hepatoma (22) 22
liver neoplasms - virology (22) 22
resistance (22) 22
mutations (21) 21
prognosis (21) 21
seroconversion (21) 21
virus-infection (21) 21
abridged index medicus (20) 20
epidemiology (20) 20
hepatitis b surface antigen (20) 20
hepatitis b, chronic - diagnosis (20) 20
hong kong (20) 20
medicine (20) 20
replication (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 2006, Volume 66, Issue 12, pp. 1623 - 1624
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 07/2011, Volume 106, Issue 7, pp. 1264 - 1271
Journal Article
Hepatology, ISSN 0270-9139, 11/2013, Volume 58, Issue 5, pp. 1857 - 1857
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 03/2009, Volume 24, Issue 3, pp. 346 - 353
Primary liver cancer, particularly hepatocellular carcinoma (HCC) remains a significant disease worldwide. It is among the top three causes of cancer death in... 
prevalence | mortality and etiology | incidence | hepatocellular carcinoma | Hepatocellular carcinoma | Mortality and etiology | Prevalence | Incidence | DIAGNOSIS | HEPATITIS-C INFECTION | GEOGRAPHIC VARIATIONS | VIRUS-INFECTION | CLINICAL-FEATURES | HONG-KONG | TRENDS | DIABETES-MELLITUS | COMMUNITY-BASED LINKAGE | PRIMARY LIVER-CANCER | GASTROENTEROLOGY & HEPATOLOGY | Carcinoma, Hepatocellular - epidemiology | Carcinoma, Hepatocellular - mortality | Prognosis | Age Factors | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Hepatitis C, Chronic - complications | Liver Neoplasms - mortality | Liver Neoplasms - etiology | Liver Neoplasms - epidemiology | Adult | Female | Carcinoma, Hepatocellular - etiology | Hepatitis C, Chronic - epidemiology | Odds Ratio | Carcinoma, Hepatocellular - ethnology | Risk Assessment | Hepatitis B, Chronic - epidemiology | Risk Factors | Liver Neoplasms - ethnology | Asia - epidemiology | Asian Continental Ancestry Group | Hepatitis B, Chronic - complications | Sex Factors | Carcinoma, Hepatocellular - therapy | Hepatitis B, Chronic, epidemiology | Asia, epidemiology | Liver Neoplasms, ethnology | Liver Neoplasms, therapy | Carcinoma, Hepatocellular, ethnology | Liver Neoplasms, etiology | Hepatitis C, Chronic, epidemiology | Carcinoma, Hepatocellular, mortality | Carcinoma, Hepatocellular, epidemiology | Carcinoma, Hepatocellular, etiology | Liver Neoplasms, epidemiology | Hepatitis B, Chronic, complications | Liver Neoplasms, mortality | Carcinoma, Hepatocellular, therapy | Hepatitis C, Chronic, complications | Liver cancer | Vaccination | Mortality | Transplantation of organs, tissues, etc | Development and progression | Hepatoma | Diabetes | Hepatitis C | Health aspects | Risk factors
Journal Article
Hepatology, ISSN 0270-9139, 11/2013, Volume 58, Issue 5, pp. 1857 - 1857
Journal Article
Hepatology, ISSN 0270-9139, 11/2013, Volume 58, Issue 5, pp. 1857 - 1857
Journal Article
Hepatology, ISSN 0270-9139, 11/2013, Volume 58, Issue 5, p. 1857
Journal Article
The Lancet, ISSN 0140-6736, 11/2018, Volume 392, Issue 10161, pp. 2313 - 2324
Chronic hepatitis B virus infection is a global public health threat that causes considerable liver-related morbidity and mortality. It is acquired at birth or... 
MEDICINE, GENERAL & INTERNAL | TENOFOVIR DISOPROXIL FUMARATE | HEPATOCELLULAR-CARCINOMA | CHRONIC LIVER-FAILURE | PERSISTENTLY NORMAL ALT | NUCLEOS(T)IDE ANALOG THERAPY | E-ANTIGEN SEROCONVERSION | TERM-FOLLOW-UP | RANDOMIZED CONTROLLED-TRIAL | TREATMENT-NAIVE PATIENTS | RNA INTERFERENCE THERAPY | Liver - pathology | Hepatitis B, Chronic - immunology | Humans | Middle Aged | Male | Liver Cirrhosis - diagnostic imaging | Vaccination - methods | World Health Organization - organization & administration | Liver - diagnostic imaging | Aged, 80 and over | Adult | Female | Ultrasonography - methods | Liver Cirrhosis - drug therapy | Nucleosides - therapeutic use | Nucleosides - administration & dosage | Hepatitis B, Chronic - epidemiology | Liver - metabolism | Risk Factors | Hepatitis B, Chronic - mortality | Disease Progression | Liver - chemistry | DNA, Viral - blood | Hepatitis B virus - drug effects | Hepatitis B, Chronic - drug therapy | Hepatitis B virus - genetics | Liver Cirrhosis - pathology | Aged | Ultrasound imaging | Liver | Vaccination | Mortality | Development and progression | Risk factors | Prevention | Disease transmission | China | Hepatitis B virus | Health aspects | Public health | Hepatitis B | Immunization | Complications | Health risks | Chronic infection | Viruses | Infections | Genomes | Vaccines | Risk analysis | Epidemiology | Morbidity | Hepatitis | Ultrasonography | Fibrosis | Drug dosages | Deoxyribonucleic acid--DNA | Hepatitis delta virus
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 01/2013, Volume 57, Issue 1, p. 399
  Chronic hepatitis B (CHB) infection is the major cause of hepatocellular carcinoma (HCC). Primary prevention of hepatitis B infection by vaccination is... 
Liver cancer | Hepatitis | Hepatology | Infections | Liver cirrhosis
Journal Article
Journal of Hepatology, ISSN 0168-8278, 04/2019, Volume 70, Issue 1, pp. e553 - e553
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 06/2017, Volume 112, Issue 6, pp. 970 - 970
Journal Article
The Lancet, ISSN 0140-6736, 12/2003, Volume 362, Issue 9401, pp. 2089 - 2094
More than 400 million people worldwide are chronically infected by the hepatitis B virus. The virus is responsible for more than 300000 cases of liver cancer... 
MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | VIRUS-INFECTION | GENOTYPE-B | DECOMPENSATED CIRRHOSIS | ADEFOVIR DIPIVOXIL | HBEAG SEROCONVERSION | LAMIVUDINE THERAPY | DNA LEVELS | HBV INFECTION | INTERFERON THERAPY | Interferon-alpha - pharmacology | HIV Infections - epidemiology | Humans | Hepatitis B - virology | Reverse Transcriptase Inhibitors - pharmacology | Hepatitis B - epidemiology | Viral Load | Adenine - therapeutic use | Lamivudine - therapeutic use | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Antiviral Agents - pharmacology | Adenine - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Hepatitis B, Chronic - epidemiology | Interferon-alpha - therapeutic use | Genotype | Adenine - pharmacology | Hepatitis B, Chronic - virology | Organophosphonates | Hepatitis B virus - drug effects | Hepatitis B, Chronic - drug therapy | Hepatitis B - drug therapy | Hepatitis B virus - genetics | HIV Infections - drug therapy | Lamivudine - pharmacology | Hepatitis B virus - isolation & purification | Diagnosis | Demographic aspects | Drug therapy | Hepatitis B | Hepatitis | Medical treatment | Diagnostic tests | Viruses | Epidemiology | Liver cirrhosis | Liver | Infections | Vaccines | Hemorrhage | Liver cancer | Child development | Adefovir dipivoxil | Hepatitis B virus | Genotypes | Age | Deoxyribonucleic acid--DNA | Lamivudine | Molecular chains | Cirrhosis | Adefovir | Fibrosis | Interferon | Mutation | Acupuncture | Hepatitis C virus | Hepatitis C | Ascites | Nucleoside analogs | Cancer
Journal Article